Visual Studio Code 1.121 focuses on agent workflows, model configuration, terminal behavior and built-in preview features -- and features another update to Claude Code functionality.

A critical vulnerability in the popular Node.js sandboxing library vm2 allows escaping the sandbox and executing arbitrary code on the host system. The security issue is tracked as CVE-2026-26956 and ...

Microsoft has released VS Code 1.121 with remote AI agents, Mermaid rendering, HTML previews, and terminal optimizations.

Microsoft is increasingly treating Claude as a first-class option across dev tooling and AI products. For one prominent example of that trend, Microsoft's Visual Studio Code editor is extending Claude ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

What's CODE SWITCH? It's the fearless conversations about race that you've been waiting for. Hosted by journalists of color, our podcast tackles the subject of race with empathy and humor. We explore ...

For decades, many runners, and even coaches, have assumed that being a runner meant never walking during a training run or race. Even the most accomplished runners would apologize when they walked at ...

May 9, 2026 • The passage of the 1965 Voting Rights Act marked what many historians mark as the actual beginning of democracy in the US. But last week the Supreme Court gutted what was left of the ...

The Apple Studios Directors Program is an initiative focused on expanding opportunities for mid-career Directors across the US. Their goal is to identify innovative visionaries with diverse points of ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

The latest fashion news, beauty coverage, celebrity style, fashion week updates, culture reviews, and videos on Vogue.com.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip ...